OraSure director granted 46,106 restricted shares

Gagliano Nancy J reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Gagliano Nancy J reported acquisition or exercise transactions in this Form 4 filing.

OraSure Technologies director Nancy J. Gagliano received a grant of 46,106 shares of common stock as a stock award. The grant consists of restricted shares under the OraSure Technologies, Inc. Stock Award Plan, provided as compensation rather than an open-market purchase.

The restricted shares will vest in full on the earlier of June 3, 2027, or immediately before the start of the company’s 2027 annual stockholders meeting, as long as she continues serving on the board. Vesting will stop immediately if she voluntarily leaves the board, so the award is tied to ongoing service. Following this grant, she holds 185,055 shares directly.

Insider Trade Summary

Grant/Award: 46,106 shares

Grant/Award 1 txn

Insider Gagliano Nancy J

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	46,106	$0.00	$0.00

Holdings After Transaction: Common Stock — 185,055 shares (Direct)

Footnotes (1)

1. F1. Grant of restricted shares under the OraSure Technologies, Inc. Stock Award Plan, which shall vest in full upon the earlier of (i) June 3, 2027, or (ii) immediately prior to the commencement of the Company's 2027 Annual Meeting of Stockholders. Vesting shall cease immediately if the named individual voluntarily ceases to serve as a member of the Board of Directors.

Key Figures

Restricted share grant: 46,106 shares Shares after transaction: 185,055 shares Grant price: $0.00 per share +1 more

4 metrics

Restricted share grant 46,106 shares Common Stock award on June 3, 2026

Shares after transaction 185,055 shares Total direct holdings following grant

Grant price $0.00 per share Stock award under Stock Award Plan

Vesting date trigger June 3, 2027 Full vesting date alternative to 2027 annual meeting

Key Terms

restricted shares, Stock Award Plan, Annual Meeting of Stockholders, vesting

4 terms

restricted shares financial

"Grant of restricted shares under the OraSure Technologies, Inc. Stock Award Plan"

Restricted shares are company stock that cannot be sold or transferred immediately because they are subject to legal or contractual limits, such as a required holding period or performance conditions. They matter to investors because these locked-up shares can affect a company’s available stock for trading, future dilution, and insider incentives—imagine a gift that can’t be cashed until certain conditions are met, which changes when and how much supply can suddenly enter the market.

Stock Award Plan financial

"Grant of restricted shares under the OraSure Technologies, Inc. Stock Award Plan"

A stock award plan is a company program that gives employees, executives or board members shares or the right to shares as part of their pay, usually becoming theirs over time or when certain goals are met. Investors care because these awards can change how many shares exist (dilution), signal how management is being motivated, and affect future earnings per share—think of it as paying staff with future slices of the company’s pie to align incentives.

Annual Meeting of Stockholders financial

"immediately prior to the commencement of the Company's 2027 Annual Meeting of Stockholders"

vesting financial

"Vesting shall cease immediately if the named individual voluntarily ceases to serve"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did OraSure Technologies (OSUR) director Nancy Gagliano report on this Form 4?

Nancy J. Gagliano reported receiving 46,106 restricted shares of OraSure Technologies common stock as a stock award. The shares were granted at $0.00 per share as part of the company’s Stock Award Plan, reflecting director compensation rather than a market purchase.

How many OraSure Technologies (OSUR) shares does Nancy Gagliano hold after the grant?

After the grant, Nancy J. Gagliano directly holds 185,055 shares of OraSure Technologies common stock. This total includes the newly awarded 46,106 restricted shares, which are subject to vesting conditions tied to her continued board service through the 2027 timeframe.

When do Nancy Gagliano’s new restricted OraSure (OSUR) shares vest?

The 46,106 restricted shares vest in full on the earlier of June 3, 2027, or immediately before OraSure Technologies’ 2027 Annual Meeting of Stockholders. Vesting depends on her continued service as a board member until that time without voluntarily stepping down.

What happens to the restricted OraSure (OSUR) shares if Nancy Gagliano leaves the board?

If Nancy J. Gagliano voluntarily stops serving on the OraSure Technologies board, vesting ceases immediately. This means unvested restricted shares from the 46,106-share grant would not continue to vest, tying the benefit directly to her ongoing director service.

Was Nancy Gagliano’s OraSure (OSUR) share grant an open-market purchase or a compensation award?

The transaction is a compensation award, not an open-market purchase. The Form 4 uses transaction code “A” for a grant or award, with a per-share price of $0.00, and the footnote specifies it is under the OraSure Technologies Stock Award Plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/05/2026 - 04:01 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Gagliano Nancy J

(Last) (First) (Middle)

220 EAST FIRST STREET

(Street)

BETHLEHEM PENNSYLVANIA 18015

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ORASURE TECHNOLOGIES INC [ OSUR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/03/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/03/2026		A(1)		46,106	A	$0	185,055	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Grant of restricted shares under the OraSure Technologies, Inc. Stock Award Plan, which shall vest in full upon the earlier of (i) June 3, 2027, or (ii) immediately prior to the commencement of the Company's 2027 Annual Meeting of Stockholders. Vesting shall cease immediately if the named individual voluntarily ceases to serve as a member of the Board of Directors.

	/s/ Michele Anthony, Attorney-in-Fact	06/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)